Monilial infections of the mouth (thrush) and intestinal moniliasis in infants and children.
ADVERSE REACTIONS: High oral dosage may produce nausea, vomiting and diarrhea. Tachycardia, bronchospasm, facial swelling, urticaria and non-specific myalgia have been reported rarely. Rash and hypersensitivity reactions may occur.
Oral suspension: Each mL contains: nystatin 100 000 units. Non-medicinal ingredients in alphabetical order: artificial flavouring, calcium disodium EDTA, D&C yellow #10, magnesium aluminum silicate, methylparaben, polysorbate 80, propylparaben, purified water and sucrose. Energy: < 3 kcal/mL. Bottles of 24, 48 and 100 mL and 1L with calibrated dropper. Store between 15-30oC.
Therapy should generally be continued for at least 48 hours after clinical cure to prevent relapse. When oral nystatin is given concomitantly with an oral antibacterial agent, oral nystatin should be continued at least as long as the antibacterial agent. Local treatment of chronic or resistant vaginal, oral or cutaneous moniliasis with nystatin may be supplemented with oral nystatin administration. Oral suspension: Infants and children: 100 000 units 3 to 4 times daily for oral (thrush) and intestinal moniliasis. For treatment of infections of the oral cavity, the medication should be dropped directly on the tongue by means of the calibrated dropper and retained in the mouth for as long as possible before swallowing. For treatment of intestinal infections, may be dropped directly on the tongue by means of the calibrated dropper, or may be mixed with milk, lukewarm formula, or other non-acid vehicles, or incorporated in honey, jelly or peanut butter.